The US Bankruptcy Court gave an order approving the sale of the certain assets of Immune Pharmaceuticals, Inc. on October 28, 2020. The debtor has been authorized to sell its certain assets to Discover Growth Fund, LLC for a purchase price of $0.18 million in cash pursuant to the asset purchase agreement. The seller and the buyer intend to close the sale as soon as reasonably practicable and, in any event, on or prior to 75 days from the date of execution of the APA.